Orchestra BioMed Holdings (OBIO) Total Debt (2022 - 2026)

Orchestra BioMed Holdings (OBIO) has 5 years of Total Debt data on file, last reported at $14.3 million in Q1 2026.

• On a quarterly basis, Total Debt changed 0.03% year-over-year to $14.3 million in Q1 2026; TTM through Mar 2026 was $14.3 million, a 0.03% change from a year earlier, with the FY2025 full-year figure at $14.3 million, changed 0.17% from the prior year.
• Total Debt for Q1 2026 stood at $14.3 million, roughly flat from $14.3 million in the prior quarter.
• Over the last five years, Total Debt for OBIO reached as high as $14.4 million in Q2 2025 and fell as low as $9.5 million in Q4 2022.
• Historically, Total Debt has averaged $12.4 million across 5 years, with a median of $14.2 million in 2025.
• Across the five-year window, Total Debt retreated 0.17% in 2025 and retreated 0.03% in 2026, its largest moves.
• Year by year, Total Debt stood at $9.5 million in 2022, then grew by 1.15% to $9.6 million in 2023, then surged by 48.89% to $14.3 million in 2024, then fell by 0.17% to $14.3 million in 2025, then gained by 0.46% to $14.3 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $14.3 million in Q1 2026, $14.3 million in Q4 2025, and $14.2 million in Q3 2025.